Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-007 · Risk category
CV-04: 10-year ASCVD risk category
10-year ASCVD risk category. Evaluates 10-year risk entered from the Pooled Cohort Equations, age 40 to 79, no established ASCVD.
Condition
- 10-year risk entered from the Pooled Cohort Equations, age 40 to 79, no established ASCVD
What it reports
- Low: below 5%
- Borderline: 5% to under 7.5%
- Intermediate: 7.5% to under 20%
- High: 20% or above
Diagnostic boundary
- Categories apply to the Pooled Cohort Equations only.
Evidence
- EV-ACCAHA-CHOL-2018Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143.Supports: Risk categories, risk enhancers, statin benefit groups and the coronary-calcium decision aid Very-high-risk ASCVD definition
- EV-ACCAHA-PREV-2019Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11):e596-e646.Supports: Primary prevention approach, risk estimation and modifiable risk factors
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
CVR-FX-05
Intermediate risk 12% with enhancers
Family history and an hs-CRP of 3.4.
CVR-FX-06
Borderline risk 6.0%, no enhancers
Nothing to push the decision either way.
CVR-FX-07
Low risk 2.1%
A 45-year-old with a normal profile.
CVR-FX-08
High risk 23%
Above the 20% line.
CVR-FX-10
Lp(a) 180 nmol/L
An elevated Lp(a) in intermediate risk.
CVR-FX-11
Lp(a) never measured, family history of premature ASCVD
A one-time measurement prompt.
CVR-FX-12
apoB 138 with LDL-C 115
Particle burden above what LDL-C suggests.
CVR-FX-15
Intermediate risk with a coronary calcium score of 0
May reasonably defer, with no exceptions present.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.